173 related articles for article (PubMed ID: 30253336)
1. 1,2,4-Triazole-based benzothiazole/benzoxazole derivatives: Design, synthesis, p38α MAP kinase inhibition, anti-inflammatory activity and molecular docking studies.
Tariq S; Kamboj P; Alam O; Amir M
Bioorg Chem; 2018 Dec; 81():630-641. PubMed ID: 30253336
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1,2,4-triazole-based benzothiazole-2-amines.
Tariq S; Alam O; Amir M
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700304. PubMed ID: 29611883
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anti-inflammatory, p38α MAP kinase inhibitory activities and molecular docking studies of quinoxaline derivatives containing triazole moiety.
Tariq S; Alam O; Amir M
Bioorg Chem; 2018 Feb; 76():343-358. PubMed ID: 29227918
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, evaluation and docking of novel pyrazolo pyrimidines as potent p38α MAP kinase inhibitors with improved anti-inflammatory, ulcerogenic and TNF-α inhibitory properties.
Somakala K; Tariq S; Amir M
Bioorg Chem; 2019 Jun; 87():550-559. PubMed ID: 30928877
[TBL] [Abstract][Full Text] [Related]
5. Substituted Benzamides from Anti-inflammatory and p38 Kinase Inhibitors to Antitubercular Activity: Design, Synthesis and Screening.
Kulkarni R; Mitkari U; Achaiah G; Laufer S; Bikshapti DVRN; Chandrashekar VM; Gurav PB; Joshi SJ; Chipade VD
Mini Rev Med Chem; 2018; 18(17):1486-1497. PubMed ID: 28685700
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Antifungal Activities and Molecular Docking Studies of Benzoxazole and Benzothiazole Derivatives.
Luo B; Li D; Zhang AL; Gao JM
Molecules; 2018 Sep; 23(10):. PubMed ID: 30257495
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation, and in silico studies of quinoxaline derivatives as potent p38α MAPK inhibitors.
Anjali ; Kamboj P; Alam O; Patel H; Ahmad I; Ahmad SS; Amir M
Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300301. PubMed ID: 37847883
[TBL] [Abstract][Full Text] [Related]
8. Aryl/heteroaryl Substituted Celecoxib Derivatives as COX-2 Inhibitors: Synthesis, Anti-inflammatory Activity and Molecular Docking Studies.
Madhava G; Ramana KV; Sudhana SM; Rao DS; Kumar KH; Lokanatha V; Rani AU; Raju CN
Med Chem; 2017; 13(5):484-497. PubMed ID: 28228088
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 2-mercapto benzothiazole and 1,2,3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities.
Shafi S; Alam MM; Mulakayala N; Mulakayala C; Vanaja G; Kalle AM; Pallu R; Alam MS
Eur J Med Chem; 2012 Mar; 49():324-33. PubMed ID: 22305614
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and anti-inflammatory activity of imidazol-5-yl pyridine derivatives as p38α/MAPK14 inhibitor.
Ali EMH; Abdel-Maksoud MS; Hassan RM; Mersal KI; Ammar UM; Se-In C; He-Soo H; Kim HK; Lee A; Lee KT; Oh CH
Bioorg Med Chem; 2021 Feb; 31():115969. PubMed ID: 33422910
[TBL] [Abstract][Full Text] [Related]
11. Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.
Nam MH; Park M; Park H; Kim Y; Yoon S; Sawant VS; Choi JW; Park JH; Park KD; Min SJ; Lee CJ; Choo H
ACS Chem Neurosci; 2017 Jul; 8(7):1519-1529. PubMed ID: 28332824
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, molecular docking, and pharmacological evaluation of N-(2-(3,5-dimethoxyphenyl)benzoxazole-5-yl)benzamide derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Wakode S
Arch Pharm (Weinheim); 2018 Jun; 351(6):e1800008. PubMed ID: 29741797
[TBL] [Abstract][Full Text] [Related]
13. New methyl 5-(halomethyl)-1-aryl-1H-1,2,4-triazole-3-carboxylates as selective COX-2 inhibitors and anti-inflammatory agents: Design, synthesis, biological evaluation, and docking study.
Li SM; Tsai SE; Chiang CY; Chung CY; Chuang TJ; Tseng CC; Jiang WP; Huang GJ; Lin CY; Yang YC; Fuh MT; Wong FF
Bioorg Chem; 2020 Nov; 104():104333. PubMed ID: 33142408
[TBL] [Abstract][Full Text] [Related]
14. Novel anti-inflammatory and analgesic agents: synthesis, molecular docking and in vivo studies.
Ugwu DI; Okoro UC; Ukoha PO; Gupta A; Okafor SN
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):405-415. PubMed ID: 29372659
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, characterization, and in vivo pharmacological evaluation of novel mannich bases derived from 1,2,4-triazole containing a naproxen moiety.
Avci A; Taşci H; Kandemir Ü; Can ÖD; Gökhan-Kelekçi N; Tozkoparan B
Bioorg Chem; 2020 Jul; 100():103892. PubMed ID: 32388433
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and molecular docking studies of new furochromone derivatives as p38α MAPK inhibitors targeting human breast cancer MCF-7 cells.
Amin KM; Syam YM; Anwar MM; Ali HI; Abdel-Ghani TM; Serry AM
Bioorg Med Chem; 2017 Apr; 25(8):2423-2436. PubMed ID: 28291685
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and anti-inflammatory activity of 2-substituted-((N, N-disubstituted)-1, 3-benzoxazole)-5-carboxamides.
Reena M; Kiran G; Rajyalakshmi G; Venkateshwa RJ; Sarangapani M
Yao Xue Xue Bao; 2010 Jun; 45(6):730-4. PubMed ID: 20939181
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation and docking study of N-(2-(3,4,5-trimethoxybenzyl)benzoxazole-5-yl) benzamide derivatives as selective COX-2 inhibitor and anti-inflammatory agents.
Kaur A; Pathak DP; Sharma V; Narasimhan B; Sharma P; Mathur R; Wakode S
Bioorg Chem; 2018 Dec; 81():191-202. PubMed ID: 30138907
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, anti-inflammatory activity, and molecular docking studies of perimidine derivatives containing triazole.
Zhang HJ; Wang XZ; Cao Q; Gong GH; Quan ZS
Bioorg Med Chem Lett; 2017 Sep; 27(18):4409-4414. PubMed ID: 28823493
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, anti-inflammatory, analgesic and kinase (CDK-1, CDK-5 and GSK-3) inhibition activity evaluation of benzimidazole/benzoxazole derivatives and some Schiff's bases.
Sondhi SM; Singh N; Kumar A; Lozach O; Meijer L
Bioorg Med Chem; 2006 Jun; 14(11):3758-65. PubMed ID: 16480879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
